EPIC CONVERSION

Hi all

We are excited to announce that on September 12, 2017 we will be converting to a new Electronic Medical Record (EMR)

Some of the benefits are outlined below:

  • smoother scheduling and registration saving time for our patients and families
  • simplified, easy to understand statements and online bill pay
  • access to a new patient portal – “MY CHART” where you can send and receive messages with your care team, get copies of camp and school forms and much more..
  • Please arrive at least 15 minutes before your scheduled appointment time

Thank you in advance for your patience through the transition- “It’s going to be EPIC!”

Read More

FLU VACCINES ARE IN!!!

We are pleased to announce that we are having drop in hours for flu vaccine administration this year. Please stop by our office on Thursdays between the hours of 10 am and 6 pm.

As a reminder: The Center for Disease Control recommends flu vaccine for all patients aged 6 months and older.

Please do not come for the vaccine if your child has a fever and or moderate to severe illness. If your child has had an allergic reaction to eggs in the past, please call to schedule your flu vaccine for a different time.

Read More

NEW FACES AT RPA

We are excited to announce that Dr. George Atkinson will be joining the RPA family this fall.

Dr. Atkinson will join Roslindale Pediatrics in November of 2017. Since he completed his Pediatrics residency at the Tufts Floating Hospital for Children in 2014, he has been working as a general pediatrician in the Boston area. He has a particular interest in dietary counseling around obesity and exercise science. Dr. Atkinson graduated from Vanderbilt University with a BS in Bioethics and then attended the Medical Scientist Training Program (MSTP) at the University of Alabama in Birmingham, where he earned both his MD and a PhD degree. His PhD was earned in the department of Cell Biology. In his free time, George enjoys biking, reading and watchmaking. We look forward to him joining the RPA team this fall.

You may also notice some new faces at our lab. There are new phlebotomists covering in the Quest lab. They are excited to be here and we are happy to have them covering until we find our permanent person.

Read More

We are listening!

A big thanks to those of you that have completed our survey. We are striving to make your experience here excellent.

As a result of feedback here are some of the improvements that are happening.

  • Our child safety locks for the rooms have arrived and will be installed soon
  • We will be reinstituting the books in the rooms soon- in the meantime we do have children’s books in the waiting rooms
  • Thanks for your patience as we continue to add more decorations to the patient rooms

Keep your eyes out for more improvements in the upcoming months! Keep the suggestions coming.

RPApatientfeedback@gmail.com

https://www.surveymonkey.com/r/3JKPV3H

Read More

Tick Guidelines

It is a great time of year to enjoy the outdoors, but make sure you and your kids are safe.  The AAP has some great guidelines about ticks.  Click on the link below for information.  If you have anymore questions, please give us a call.

tick guidelines

 

Read More

EPIPEN RECALL

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall
of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.
While the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. Consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers should contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions.
As stated on the product label, consumers should always seek emergency medical help right away after using their EpiPens, particularly if the device did not activate.
At this time, the 13 lots identified – distributed between Dec. 17, 2015, and July 1, 2016 – are the only EpiPen lots impacted by the U.S. recall. Consumers who have EpiPens from lots that are not included in this recall, do not need to replace their EpiPen prior to its expiration date.
Product/Dosage NDC Number Lot Number Expiration Date
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN767 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN773 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM631 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM640 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 6GN215 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM082 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM072 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM081 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM088 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM199 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM091 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM198 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM087 October 2017
Read More